$AKER MyMD Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in MyMD Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MyMD Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in MyMD Pharmaceuticals, Inc. for free.
CIK Number: 0001321834
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: AKER
Company Address: 855 N. WOLFE STREET SUITE 623 BALTIMORE 21205
Phone number: (856) 848-8698
Former name: Akers Biosciences Inc, date of change: 2005-03-25
Former name: None
Market Capitalization: $6.82M
Prev close: $1.25
Average Daily Volume: 69,032
Days Low: $1.20
Year Low: $1.15
Year High: $3.70
MyMD Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | AKER | MyMD Pharmaceutica ... | EAGLE CRAIG | Director | Option Exercise | A | 2.59 | 482,375 | 1,249,978 | 482,375 | |
Apr 22 2021 | AKER | MyMD Pharmaceutica ... | EAGLE CRAIG | Director | Option Exercise | A | 2.59 | 482,375 | 1,249,978 | 482,375 | |
Apr 21 2021 | AKER | MyMD Pharmaceutica ... | Schreiber Christopher C | Director | Option Exercise | M | 0.00 | 131,750 | 0 | 0 | |
Apr 21 2021 | AKER | MyMD Pharmaceutica ... | Schreiber Christopher C | Director | Payment of Exercise | F | 4.94 | 46,113 | 227,798 | 88,238 | 134.4 K to 88.2 K (-34.32 %) |
Apr 21 2021 | AKER | MyMD Pharmaceutica ... | Schreiber Christopher C | Director | Buy | M | 0.00 | 131,750 | 0 | 134,351 | 2.6 K to 134.4 K (+5,065.36 %) |
Apr 21 2021 | AKER | MyMD Pharmaceutica ... | Kaplin Adam | Chief Scientific Of ... | Option Exercise | A | 2.59 | 154,360 | 399,993 | 154,360 | |
Apr 21 2021 | AKER | MyMD Pharmaceutica ... | Kaplin Adam | Chief Scientific Of ... | Option Exercise | A | 2.59 | 154,360 | 399,993 | 154,360 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Rivard Paul | EVP of Operations, ... | Option Exercise | A | 2.59 | 77,180 | 199,997 | 77,180 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Rivard Paul | EVP of Operations, ... | Option Exercise | A | 2.59 | 77,180 | 199,997 | 77,180 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Rivard Paul | EVP of Operations, ... | Option Exercise | A | 2.59 | 77,180 | 199,997 | 77,180 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Rivard Paul | EVP of Operations, ... | Option Exercise | A | 2.59 | 77,180 | 199,997 | 77,180 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Option Exercise | M | 0.00 | 43,930 | 0 | 0 | |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Payment of Exercise | F | 4.94 | 14,694 | 72,588 | 29,236 | 43.9 K to 29.2 K (-33.45 %) |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Buy | M | 0.00 | 43,930 | 0 | 43,930 | 0 to 43.9 K |
Apr 20 2021 | AKER | MyMD Pharmaceutica ... | Silverman Joshua | Director | Option Exercise | M | 0.00 | 109,500 | 0 | 0 |